Genetics, Vol 140, 255-265, Copyright © 1995

INVESTIGATIONS

Molecular Genetic Characterization of Six Recessive Viable Alleles of the Mouse agouti Locus

C. M. Hustad, W. L. Perry, L. D. Siracusa, C. Rasberry, L. Cobb, B. M. Cattanach, R. Kovatch, N. G. Copeland and N. A. Jenkins
Mammalian Genetics Laboratory, ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702

The agouti locus on mouse chromosome 2 encodes a secreted cysteine-rich protein of 131 amino acids that acts as a molecular switch to instruct the melanocyte to make either yellow pigment (phaeomelanin) or black pigment (eumelanin). Mutations that up-regulate agouti expression are dominant to those causing decreased expression and result in yellow coat color. Other associated effects are obesity, diabetes, and increased susceptibility to tumors. To try to define important functional domains of the agouti protein, we have analyzed the molecular defects present in a series of recessive viable agouti mutations. In total, six alleles (a(mJ), a(u), a(da), a(16H), a(18H), a(e)) were examined at both the RNA and DNA level. Two of the alleles, a(16H) and a(e), result from mutations in the agouti coding region. Four alleles (a(mJ), a(u), a(18H), and a(da)) appear to represent regulatory mutations that down-regulate agouti expression. Interestingly, one of these mutations, a(18H), also appears to cause an immunological defect in the homozygous condition. This immunological defect is somewhat analogous to that observed in motheaten (me) mutant mice. Short and long-range restriction enzyme analyses of homozygous a(18H) DNA are consistent with the hypothesis that a(18H) results from a paracentric inversion where one end of the inversion maps in the 5' regulatory region of agouti and the other end in or near a gene that is required for normal immunological function. Cloning the breakpoints of this putative inversion should allow us to identify the gene that confers this interesting immunological disorder.

This article has been cited by other articles:

				S. Egawa, H. Iijima, S. Shinzaki, S. Nakajima, J. Wang, J. Kondo, S. Ishii, T. Yoshio, T. Irie, T. Nishida, et al. Upregulation of GRAIL is associated with remission of ulcerative colitis Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G163 - G169. [Abstract] [Full Text] [PDF]

				V. Parravicini, A.-C. Field, P. D. Tomlinson, M. Albert Basson, and R. Zamoyska Itch-/-{alpha}{beta} and {gamma}{delta} T cells independently contribute to autoimmunity in Itchy mice Blood, April 15, 2008; 111(8): 4273 - 7282. [Abstract] [Full Text] [PDF]

				L. E. Matesic, D. C. Haines, N. G. Copeland, and N. A. Jenkins Itch genetically interacts with Notch1 in a mouse autoimmune disease model Hum. Mol. Genet., December 15, 2006; 15(24): 3485 - 3497. [Abstract] [Full Text] [PDF]

				E. Galkina and K. Ley Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy J. Am. Soc. Nephrol., February 1, 2006; 17(2): 368 - 377. [Abstract] [Full Text] [PDF]

				A. Dunne and L. O'Neill New insights into the post-translational modification of Toll-like receptor signaling molecules Innate Immunity, December 1, 2005; 11(6): 325 - 332. [Abstract] [PDF]

				A. Laine and Z. Ronai Ubiquitin Chains in the Ladder of MAPK Signaling Sci. Signal., April 26, 2005; 2005(281): re5 - re5. [Abstract] [Full Text] [PDF]

				J. M. Cerda-Reverter, T. Haitina, H. B. Schioth, and R. E. Peter Gene Structure of the Goldfish Agouti-Signaling Protein: A Putative Role in the Dorsal-Ventral Pigment Pattern of Fish Endocrinology, March 1, 2005; 146(3): 1597 - 1610. [Abstract] [Full Text] [PDF]

				M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC Mouse Models of Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2005; 16(1): 27 - 45. [Abstract] [Full Text] [PDF]

				G. F. Hoyne Notch signaling in the immune system J. Leukoc. Biol., December 1, 2003; 74(6): 971 - 981. [Abstract] [Full Text]

				C. A. Welsch, S. Hagiwara, J. F. Goetschy, and N. R. Movva Ubiquitin Pathway Proteins Influence the Mechanism of Action of the Novel Immunosuppressive Drug FTY720 in Saccharomyces cerevisiae J. Biol. Chem., July 11, 2003; 278(29): 26976 - 26982. [Abstract] [Full Text] [PDF]

				T.-F. Tsai, K.-S. Chen, J. S. Weber, M. J. Justice, and A. L. Beaudet Evidence for translational regulation of the imprinted Snurf-Snrpn locus in mice Hum. Mol. Genet., July 1, 2002; 11(14): 1659 - 1668. [Abstract] [Full Text] [PDF]

				R. J. Miltenberger, K. Wakamatsu, S. Ito, R. P. Woychik, L. B. Russell, and E. J. Michaud Molecular and Phenotypic Analysis of 25 Recessive, Homozygous-Viable Alleles at the Mouse agouti Locus Genetics, February 1, 2002; 160(2): 659 - 674. [Abstract] [Full Text] [PDF]

				T. M. Gunn, T. Inui, K. Kitada, S. Ito, K. Wakamatsu, L. He, D. M. Bouley, T. Serikawa, and G. S. Barsh Molecular and Phenotypic Analysis of Attractin Mutant Mice Genetics, August 1, 2001; 158(4): 1683 - 1695. [Abstract] [Full Text] [PDF]

				R. J. Miltenberger, R. L. Mynatt, B. D. Bruce, W. O. Wilkison, R. P. Woychik, and E. J. Michaud An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice PNAS, July 20, 1999; 96(15): 8579 - 8584. [Abstract] [Full Text] [PDF]

				M. K. Shin, L. B. Russell, and S. M. Tilghman Molecular characterization of four induced alleles at the Ednrb locus PNAS, November 25, 1997; 94(24): 13105 - 13110. [Abstract] [Full Text] [PDF]

				R. J. Miltenberger, R. L. Mynatt, J. E. Wilkinson, and R. P. Woychik The Role of the agouti Gene in the Yellow Obese Syndrome J. Nutr., September 1, 1997; 127(9): 1902 - 1902. [Abstract] [Full Text]

				L. Qiu, C. Joazeiro, N. Fang, H.-Y. Wang, C. Elly, Y. Altman, D. Fang, T. Hunter, and Y.-C. Liu Recognition and Ubiquitination of Notch by Itch, a Hect-type E3 Ubiquitin Ligase J. Biol. Chem., November 10, 2000; 275(46): 35734 - 35737. [Abstract] [Full Text] [PDF]